888-416-9305 info@abterrabio.com

Griffin Overview

 

Griffin for Polyclonal Antibody Sequencing

 

  • Are you suffering from batch-to-batch variability in your polyclonal antibodies?
  • Are you having trouble sourcing donors with the needed reactivity?
  • Sick of poorly characterized products in your assays?

 

Griffin brings your polyclonal antibody into the bioreactor

A 3 stage process de-risks your project with Go/No Go decision points

STAGE 1

Assess clonality to determine complexity and specificities.

Polyclonal antibody sequencing stage 1 sequences CDR3s and clusters similar antibodies to assess clonality.

STAGE 2

Full-length antibody sequencing and assembly.

Eclipse Mass Spectrometer for Griffin sequencing and assembly

STAGE 3

Expression and validation

Curious to see what’s in your polyclonal?

 

Griffin Deliverables

 

Sequences – Full sequence information for all hits identified by Griffin.

Binding report – Binding evaluation of all sequences.

Expressed antibodies – Transient production of candidates.

Get In Touch

Tell Us About Your Project.

Need more information? We’re here to answer any questions you have.

Resources and Publications

Alicanto® integrates next-generation sequencing analysis of antibody repertoires with computational mass spectrometry measurements of antibody proteins. The early algorithmic foundation for Alicanto® was developed at the Computer Science and Engineering Department at the University of California – San Diego.

Publications by Abterra Bio founders and team members include: